Sight Sciences (SGHT) Total Non-Current Liabilities (2020 - 2026)

Sight Sciences' (SGHT) quarterly Total Non-Current Liabilities came in at $54.9 million in Q1 2026, up 6.18% year-on-year from $51.7 million in Q1 2025, and up 6.96% quarter-over-quarter from $51.3 million in Q4 2025.

Sight Sciences (SGHT) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends

Sight Sciences' Total Non-Current Liabilities history runs 7 years deep, the most recent figure standing at $54.9 million for Q1 2026.

  • On a quarterly basis, Total Non-Current Liabilities rose 6.18% year-over-year to $54.9 million in Q1 2026; TTM through Mar 2026 was $54.9 million, a 6.18% increase from a year earlier, with the FY2025 full-year figure at $51.3 million, down 6.38% from the prior year.
  • Total Non-Current Liabilities advanced to $54.9 million in Q1 2026 per SGHT's latest filing, from $51.3 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $54.9 million in Q1 2026 and bottomed at $44.0 million in Q4 2023.
  • The 5-year median for Total Non-Current Liabilities is $50.2 million (2023), against an average of $49.8 million.
  • Across the five-year window, Total Non-Current Liabilities fell 16.99% in 2023 and increased 24.71% in 2024, its largest moves.
  • Year by year, Total Non-Current Liabilities stood at $53.0 million in 2022, then dropped by 16.99% to $44.0 million in 2023, then gained by 24.71% to $54.8 million in 2024, then decreased by 6.38% to $51.3 million in 2025, then grew by 6.96% to $54.9 million in 2026.
  • Per Business Quant, the three latest SGHT Total Non-Current Liabilities figures stand at $54.9 million (Q1 2026), $51.3 million (Q4 2025), and $51.9 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 20.94 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 41.44 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 41.88 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 2.64 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 3.53 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 9.85 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 24.21 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 3.57 Bn
10 Sight Sciences 253.53 Mn 168.57 Mn 16.98 Mn 54.90 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 54.90 Mn
Dec 31, 2025 51.33 Mn
Sep 30, 2025 51.95 Mn
Jun 30, 2025 51.76 Mn
Mar 31, 2025 51.71 Mn
Dec 31, 2024 54.82 Mn
Sep 30, 2024 48.57 Mn
Jun 30, 2024 47.06 Mn
Mar 31, 2024 45.39 Mn
Dec 31, 2023 43.96 Mn
Sep 30, 2023 48.10 Mn
Jun 30, 2023 49.12 Mn
Mar 31, 2023 50.23 Mn
Dec 31, 2022 52.96 Mn
Sep 30, 2022 50.54 Mn
Jun 30, 2022 47.18 Mn
Mar 31, 2022 46.64 Mn
Dec 31, 2021 46.16 Mn
Sep 30, 2021 44.73 Mn
Jun 30, 2021 44.36 Mn